ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 146 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,021,409 | -60.4% | 41,947 | -61.0% | 0.00% | -66.7% |
| Q1 2023 | $2,580,443 | -84.8% | 107,653 | -89.3% | 0.01% | -87.2% |
| Q4 2022 | $17,031,826 | +238.6% | 1,004,235 | +195.9% | 0.05% | +213.3% |
| Q3 2022 | $5,030,000 | +2858.8% | 339,383 | +3039.8% | 0.02% | +1400.0% |
| Q2 2022 | $170,000 | -85.1% | 10,809 | -59.4% | 0.00% | -87.5% |
| Q3 2020 | $1,142,000 | -80.2% | 26,628 | -78.4% | 0.01% | -84.0% |
| Q2 2020 | $5,766,000 | – | 123,378 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |